Term Pregnancy Women with Human Immunodeficiency Virus Infection Receiving Antiretroviral Threapy as A Risk Factor for Low Expression of Mitochondiral Deoxyribose-Nucleic Acid in Placenta

##plugins.themes.bootstrap3.article.main##

  •   Prayascita Mahendrata

  •   I Wayan Artana Putra

  •   Tjok. G. A. Suwardewa

  •   I Nyoman Gede Budiana

  •   I Nyoman Bayu Mahendra

  •   I Made Darmayasa

Abstract

Antiretroviral therapy (ART) given to pregnant women with Human Immunodeficiency Virus (HIV) has the effect of mitochondrial DNA (mtDNA) depletion through several steps, either directly or indirectly. This decrease may trigger the occurrence of reactive oxygen species (ROS) and mitochondrial toxicity which are characterized by energy insufficiency, cell dysfunction, and maternal and placental apoptosis. This study aimed to determine whether term pregnant women with HIV infection receiving antiretroviral therapy are risk factors for low mtDNA expression in the placenta. This cross-sectional analytic study was conducted at Sanglah Hospital Denpasar and affiliation hospitals. Inclusion samples were termed pregnant women with HIV (+) who received ART ≥ 6 months as a risk group and pregnant women with HIV (-) as a non-risk group. Expression of mtDNA was assessed by real-time Polymerase Chain Reaction (rtPCR) examination of placental samples. The estimated relative amount of mtDNA was calculated by dividing the number of mtDNA to the number of nDNA, as a reference. The cut-off value of mtDNA expression was determined by plotting a Receiver Operating Characteristics (ROC) curve. The results of the analysis found that pregnant women with HIV who received ART≥6 months had a prevalence of low mtDNA expression by 2.83 times higher than pregnant women without HIV (95% confidence interval = 1.42 – 5.67; p-value = 0.000). The conclusion of this study is that term pregnant women with HIV infection who receive ART is a risk factor for low mtRNA expression in the placental.


Keywords: Antiretroviral therapy, human immunodeficiency virus, mitochondrial DNA, term pregnancy

References

Siregar KN, Hanifah L, Rikawarastuti, Wahyuniar L. Prevention of HIV Transmission from Mother to Child: Challenges to the Successful Program Implementation and Practice in Indonesia. J Int Assoc Provid AIDS Care. 2021; 20: 23259582211040701.

Stover J, Glaubius R, Teng Y, Kelly S, Brown T, Hallett TB, et al. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030. PLoS Med. 2021; 18(10): e1003831.

Badru O, Dairo MD, Oladokun RE. Quality of Life of HIV Infected Children Attending the Antiretroviral Clinic, University College Hospital, Ibadan. West Afr J Med. 2020; 37(5): 521-527.

Morén C, Hernández S, Guitart-Mampel M, Garrabou G. Mitochondrial Toxicity in Human Pregnancy: An Update on Clinical and Experimental Approaches in the Last 10 Years. International Journal of Environmental Research and Public Health, 2014; 11(9): hh.9897-9918

Money D, Wagner E, Maan E, Chaworth-Musters T, Gadawski I, van Schalkwyk J, et al. Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women. Plos One. 2015; 10(8): h.e0135041.

Vermaak A, Theron G, Schubert P, Kidd M, Rabie U, Adjiba B, et al. Morphologic Changes in the Placentas of HIV-Positive Women and Their Association with Degree of Immune Suppression. International Journal of Gynecology & Obstetrics. 2012; 119(3): hh.239-243.

Ekouevi DK, Stringer E, Coetzee D, Tih P, Creek T, Stinson K, et al. Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL study. PLoS One. 2012; 7(1): e29823.

Negara IKS, Anantasika AAN, dan Putra IWA. Characteristics of pregnant women with HIV infection following prevention of mother to child transmission of HIV (PMTCT) program in Sanglah general hospital 2005-2014. Bali Med J. 2016; 5(1): 147-151.

Sofiyanti I, Astuti FP. Relationship between the characteristics of pregnant women and HIV testing. Indonesian Journal of Midwivery. 2018; 1(1): 49-52.

Hernández S, Moren C, Catalán-García M, Lopez M, Guitart-Mampel M, Coll O, et al. Mitochondrial toxicity and caspase activation in HIV pregnant women. Journal of Cellular and Molecular Medicine. 2017; 21(1): hh. 26-34.

Young S, Murray K, Mwesigwa J, Natureeba P, dan Osterbauer B. Maternal Nutritional Status Predicts Adverse Birth Outcomes among HIV Infected Rural Ugandan Women Receiving Combination Antiretroviral Therapy. Plos ONE. 2012; 7(8): e41934.

van der Heijden WA, van de Wijer L, Jaeger M, et al. Long-term treated HIV infection is associated with platelet mitochondrial dysfunction. Sci Rep. 2021;11(1):6246. Published 2021 Mar 18. doi:10.1038/s41598-021-85775-5

Shiramizu B, Shikuma KM, Kamemoto L, Gerschenson M, Erdem G, et al. (2003) Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 32: 370–374.

Guitart-MampeL M, Hernandez AS, Moren C, Catalan-Garcia M, Tobias E, Gonzalez-Casacuberta I, et al. Imbalance in Mitochondrial Dynamics and Apoptosis in Pregnancies Among HIV-Infected Women on HAART with Obstetric Complications. J Antimicrob Chemother. 2017; 72: hh. 2578-2586.

Ordono MS. Placental Mitochondral Dysfunction in Relation to Preterm Delivery in HIV Pregnancy. M. S. Thesis. University of British Columbia. 2014.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

How to Cite
Mahendrata, P., Artana Putra, I. W., A. Suwardewa, T. G., Budiana, I. N. G., Mahendra, I. N. B., & Darmayasa, I. M. (2022). Term Pregnancy Women with Human Immunodeficiency Virus Infection Receiving Antiretroviral Threapy as A Risk Factor for Low Expression of Mitochondiral Deoxyribose-Nucleic Acid in Placenta. European Journal of Medical and Health Sciences, 4(3), 119–122. https://doi.org/10.24018/ejmed.2022.4.3.1326

Most read articles by the same author(s)